Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 142217-81-0
2. 2-amino-1,9-dihydro-9-[(1s,3r,4s)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6h-purin-6-one
3. 3',5'-di-o-benzyl Entecavir
4. Iec6p1l62x
5. 3',5'-di-o-benzylentecavir
6. 2-amino-1,9-dihydro-9-((1s,3r,4s)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylene Cyclopentyl)-6h-purine-6-one
7. 2-amino-9-[(1s,3r,4s)-2-methylidene-4-phenylmethoxy-3-(phenylmethoxymethyl)cyclopentyl]-1h-purin-6-one
8. Entecavir-9
9. 2-amino-1,9-dihydro-9-(4-(benzyloxy)-3-(benzyloxymethyl)-2-methylene Cyclopentyl)-6h-purine-6-one, (1s,3r,4s)-
10. 6h-purin-6-one, 2-amino-1,9-dihydro-9-((1s,3r,4s)-2-methylene-4-(phenylmethoxy)-3-((phenylmethoxy)methyl)cyclopentyl)-
11. Unii-iec6p1l62x
12. 2-amino-1,9-dihydro-9-((1s,3r,4s)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-6h-purin-6-one
13. Schembl8781248
14. 2-amino-9-((1s,3r,4s)-4-(benzyloxy)-3-((benzyloxy)-methyl)-2-methylenecyclopentyl)-1h-purin-6(9h)-one
15. Mfcd11977291
16. Zinc34498392
17. Akos015896700
18. Akos025402354
19. Ac-8329
20. Am84385
21. 2-amino-1,9-dihydro-9-[(1s,3r,4s)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-6h-purin-6-one
22. 6h-purin-6-one,2-amino-1,9-dihydro-9-[(1s,3r,4s)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-
23. Ds-18052
24. Cs-0158057
25. C72661
26. 217a810
27. W-205570
28. Q27280683
29. 2-amino-9-((1s,3r,4s)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-1,9-dihydro-6h-purin-6-one
| Molecular Weight | 457.5 g/mol |
|---|---|
| Molecular Formula | C26H27N5O3 |
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 8 |
| Exact Mass | 457.21138974 g/mol |
| Monoisotopic Mass | 457.21138974 g/mol |
| Topological Polar Surface Area | 104 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 762 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Entecavir Intermediate VIII Isomer manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Entecavir Intermediate VIII Isomer, including repackagers and relabelers. The FDA regulates Entecavir Intermediate VIII Isomer manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Entecavir Intermediate VIII Isomer API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Entecavir Intermediate VIII Isomer supplier is an individual or a company that provides Entecavir Intermediate VIII Isomer active pharmaceutical ingredient (API) or Entecavir Intermediate VIII Isomer finished formulations upon request. The Entecavir Intermediate VIII Isomer suppliers may include Entecavir Intermediate VIII Isomer API manufacturers, exporters, distributors and traders.
click here to find a list of Entecavir Intermediate VIII Isomer suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Entecavir Intermediate VIII Isomer DMF (Drug Master File) is a document detailing the whole manufacturing process of Entecavir Intermediate VIII Isomer active pharmaceutical ingredient (API) in detail. Different forms of Entecavir Intermediate VIII Isomer DMFs exist exist since differing nations have different regulations, such as Entecavir Intermediate VIII Isomer USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Entecavir Intermediate VIII Isomer DMF submitted to regulatory agencies in the US is known as a USDMF. Entecavir Intermediate VIII Isomer USDMF includes data on Entecavir Intermediate VIII Isomer's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Entecavir Intermediate VIII Isomer USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Entecavir Intermediate VIII Isomer suppliers with USDMF on PharmaCompass.
Entecavir Intermediate VIII Isomer Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Entecavir Intermediate VIII Isomer GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Entecavir Intermediate VIII Isomer GMP manufacturer or Entecavir Intermediate VIII Isomer GMP API supplier for your needs.
A Entecavir Intermediate VIII Isomer CoA (Certificate of Analysis) is a formal document that attests to Entecavir Intermediate VIII Isomer's compliance with Entecavir Intermediate VIII Isomer specifications and serves as a tool for batch-level quality control.
Entecavir Intermediate VIII Isomer CoA mostly includes findings from lab analyses of a specific batch. For each Entecavir Intermediate VIII Isomer CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Entecavir Intermediate VIII Isomer may be tested according to a variety of international standards, such as European Pharmacopoeia (Entecavir Intermediate VIII Isomer EP), Entecavir Intermediate VIII Isomer JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Entecavir Intermediate VIII Isomer USP).
LOOKING FOR A SUPPLIER?
